Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Aug 27;30(25):104814.
doi: 10.1016/j.jaccas.2025.104814.

Managing Acute Myocardial Infarction in Shock and Anemia

Affiliations
Case Reports

Managing Acute Myocardial Infarction in Shock and Anemia

Mehdi Madanchi et al. JACC Case Rep. .

Abstract

Background: Patients presenting with ST-segment elevation myocardial infarction (STEMI) and concurrent anemia or active bleeding present a therapeutic dilemma.

Case summary: A 61-year-old woman with a history of pulmonary embolism and a newly discovered lung mass presented with inferior STEMI, critically low hemoglobin level, and hemodynamic instability. Coronary angiography revealed thrombotic occlusion of the posterior left ventricular and posterior descending artery. Revascularization was performed using a drug-eluting balloon (DEB)-only strategy.

Discussion: This case illustrates the need for individualized treatment in STEMI patients with cardiogenic shock and high bleeding risk. A DEB-only strategy can be a valuable approach when prolonged antiplatelet therapy is not feasible.

Take home messages: STEMI in anemic patients poses a major diagnostic challenge. Balancing thrombotic and bleeding risk is a common and challenging aspect of STEMI care. In this setting, the use of DEBs can be a viable alternative to stent implantation for patients with active bleeding.

Keywords: acute coronary syndrome; coronary angiography; myocardial infarction.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures Dr Madanchi was supported by a research grant from the Swiss National Science Foundation. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
Figure 1
Figure 1
Electrocardiogram at Initial Presentation
Figure 2
Figure 2
Initial Angiogram Showing Thrombotic Occlusion of the Posterior Descending Artery and posterior left ventricular Branches
Figure 3
Figure 3
Final Angiogram After Percutaneous Coronary Intervention With the Drug-Eluting Balloon
Visual Summary
Visual Summary
Management of Acute Myocardial Infarction in Shock and Anemia

References

    1. Rao S.V., O'Donoghue M.L., Ruel M., et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2025;151(13):e771–e862. - PubMed
    1. Sabatine M.S., Morrow D.A., Giugliano R.P., et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 2005;111(16):2042–2049. - PubMed
    1. Anker S.D., Voors A., Okonko D., et al. Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial. Eur Heart J. 2009;30(11):1331–1339. - PubMed
    1. Byrne R.A., Rossello X., Coughlan J.J., et al. 2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC) Eur Heart J. 2023;44(38):3720–3826. - PubMed
    1. Keeley E.C., Boura J.A., Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13–20. - PubMed

Publication types

LinkOut - more resources